[HTML][HTML] In silico prediction of COVID-19 cytokine storm in lung cancer types

S Suchanti, S Awasthi, G Singh, PK Yadav… - … and Biophysics Reports, 2022 - Elsevier
Lung cancer is one of the most frequently diagnosed malignant tumors and the leading
cause of cancer-related death worldwide. Mainly, Non-small-cell lung cancer (NSCLC) …

[HTML][HTML] The landscape of coronavirus disease 2019 (COVID-19) and integrated analysis SARS-CoV-2 receptors and potential inhibitors in lung adenocarcinoma …

B Tang, J Zhu, Y Cong, W Yang, C Kong… - Frontiers in Cell and …, 2020 - frontiersin.org
The outbreak of novel coronavirus disease 2019 (COVID-19) has become the largest health
threat worldwide, with more than 34.40 million positive cases and over 1.02 million deaths …

Identification of unique immune response expression profiles to SARS-CoV-2 in non-small cell lung cancer using systems immunology approach

S Al Heialy, MY Hachim, IY Hachim… - … in Biomedical and …, 2022 - journals.lww.com
Background: COVID-19 severity and mortality are higher in patients with lung cancer due to
pulmonary complications. Understanding the mechanisms of SARS-COV-2 effect on lung …

[PDF][PDF] Differential expression and immune correlation analysis of COVID-19 receptor ACE2 and TMPRSS2 genes in all normal and tumor tissues

RW Hu, C Liu, JP Gong, ZX Cao - Eur Rev Med Pharmacol Sci, 2021 - europeanreview.org
The outbreak of COVID-19 seriously affected people's life and safety, and it has not been
effectively controlled all over the world at present. The binding of S protein of SARS-COV-2 …

In silico analysis of the Key Receptors of SARS-CoV-2: ACE2 and TMPRSS2 in Head and Neck Cancer

V Mariappan, AR JeanPierre, AB Pillai - 2022 - researchsquare.com
Background It is reported that cancer patients are more susceptible to SARS-CoV-2 infection
due to immunocompromised immunity. To understand the long-term impact of SARS-CoV-2 …

Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on …

MN Uddin, R Akter, M Li, Z Abdelrahman - Chemico-Biological Interactions, 2021 - Elsevier
The aberrant expression level of SARS-CoV-2 cell receptor gene ACE2 was reported in lung
adenocarcinoma (LUAD) comorbidity of COVID-19. However, the association of ACE2 …

Risk factors and actionable molecular signatures in COVID-19-associated lung adenocarcinoma and lung squamous cell carcinoma patients

MA Ullah, S Alam, AT Moin, T Ahamed… - Computers in Biology …, 2023 - Elsevier
The molecular mechanism of the pathological impact of COVID-19 in lung cancer patients
remains poorly understood to date. In this study, we used differential gene expression …

Integrated bioinformatic analysis of SARS-CoV-2 infection related genes ACE2, BSG and TMPRSS2 in aerodigestive cancers

C He, X Hua, S Sun, S Li, J Wang… - Journal of Inflammation …, 2021 - Taylor & Francis
Background: Cancer patients are more vulnerable to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection than the general population, with lung epithelial cells …

The potential mechanism of cancer patients appearing more vulnerable to SARS-CoV-2 and poor outcomes: a pan-cancer bioinformatics analysis

X Huang, H Liang, H Zhang, L Tian, P Cong… - Frontiers in …, 2022 - frontiersin.org
To explore the potential mechanism of cancer patients appearing more vulnerable to SARS-
CoV-2 infection and poor COVID-19 outcomes, we conducted an integrative bioinformatics …

Assessment of ACE2, CXCL10 and Their co-expressed Genes: An In-silico Approach to Evaluate the Susceptibility and Fatality of Lung Cancer Patients towards …

TB Mahmood, AS Chowdhury, M Hasan, MMUI Aakil… - bioRxiv, 2020 - biorxiv.org
Background COVID-19 is a recent pandemic that started to spread out worldwide from
Wuhan, China. This disease is caused by a newly discovered strain of the coronavirus …